Nexalin technology announces closing of previously announced $5.0 million underwritten public offering

Houston, may 06, 2025 (globe newswire) --  nexalin technology, inc. (nasdaq: nxl; nxliw) (the “company” or “nexalin”), the leader in deep intracranial frequency stimulation (difs™) of the brain, today announced the closing of its previously announced underwritten public offering of 3,850,000 shares of its common stock at a public offering price of $1.30 per share. the gross proceeds from the offering to nexalin were approximately $5.0 million, before deducting underwriting discounts and commissions and other offering expenses.
NXL Ratings Summary
NXL Quant Ranking